Shazia Kadri

Papers

Total Citations

H-Index

About

Shazia Kadri is a leading figure in the field of stereotactic radiosurgery, with a focused expertise in applying CyberKnife technology to complex oncological and neurosurgical cases. Her research primarily addresses the efficacy and safety of Stereotactic Body Radiation Therapy (SBRT) for challenging tumors. Kadri’s major contribution is her pioneering work on hepatocellular carcinoma (HCC), where her 2021 study provided critical prognostic data on SBRT outcomes, offering a non-invasive lifeline for patients with limited treatment options. She has also made a significant impact on the management of pituitary adenomas; her large single-centre study from 2024, with its comprehensive analysis of clinical and radiological outcomes, stands as a vital reference for the safety and preeminence of radiosurgery in this domain. While her citation counts are currently emerging—reflecting the recent publication of her work—the clinical weight of her findings is substantial. Kadri’s research is notable for its focus on large, real-world patient cohorts, directly addressing the limitations of small sample sizes that have historically hampered the field. Her work is shaping modern, non-invasive treatment paradigms in radiation oncology.